06th November 2021 | Pharma Updates
EU regulator reviewing AstraZeneca booster shot
European Medicines Agency has already given approval to mRNA vaccine booster shots.
Ways to protect pharma supply chains from cyber attacks in 2022
One of the most recent cyber attacks has been to DRL, a leading drugmaker in India.
Ways To Transform Indian Biosimilars
At present Indian drugmakers contribute USD 500 mn to USD 600 mn in the USD 12 bn market, a large portion of this is domestic demand. Our potential is closer to USD 5-6 bn.
Cambodia's Ministry of Health authorizes India's Covaxin
The Covid vaccine is allowed to be used for people aged 18 yrs and above.
Britain is the first country to give nod to Merck's Covid pill molnupiravir
Britain became the first nation to approve Covid antiviral pill, jointly made by Merck & Co Inc and Ridgeback Biotherapeutics.
Pfizer's says its Covid vaccine cuts death risk by 90%
Pfizer added it will ask the US FDA and international drug regulators to authorize its antiviral Covid pill as early as possible.
IIIM Jammu develops herb-based pain pill
The formulation has Bergenia ciliata, which can help reduce pain in patients with rheumatoid arthritis.
